Amend Bill, page 3, line 18, by striking out "PROCUREMENT AND
DISBURSEMENT" and inserting
PLAN AND REPORTING
Amend Bill, page 3, lines 26 through 30; page 4, lines 1
through 30; page 5, lines 1 through 18; by striking out all of
said lines on said pages and inserting
"State laboratory." A State Public Health Laboratory as
authorized under section 8(d) of the act of April 27, 1905
(P.L.312, No.218), entitled "An act creating a Department of
Health, and defining its powers and duties.
Section 2102-C. COVID-19 testing plan.
(a) Submission.--Consistent with the Paycheck Protection
Program and Health Care Enhancement Act (Public Law 116-139),
the Governor or an authorized designee shall submit a plan for
COVID-19 testing to the Secretary of the United States
Department of Health and Human Services.
(b) Contents.--The plan under subsection (a) shall delineate
goals, beginning after the effective date of this section, for
the remainder of the calendar year 2020, and shall include all
of the following:
(1) The number of tests needed, month-by-month,
including diagnostic, serological and other tests, as
appropriate.
(2) Month-by-month estimates of laboratory and testing
capacity, including capacity related to workforce, equipment
and supplies and available tests.
(3) A description of how the Commonwealth will use
Federal money appropriated for COVID-19 testing, including as
it relates to easing any COVID-19 community mitigation orders
issued by the Governor.
(c) Approval or acceptance.--Upon approval or acceptance of
a plan under this section, the General Assembly shall
appropriate funds for COVID-19 testing as provided under
subsections (d) and (e).
(d) Use of funding.--Funds appropriated under subsection (c)
may be used for any of the following:
(1) Necessary expenses to research, develop, validate,
manufacture, purchase, administer and expand capacity for
COVID-19 tests to effectively monitor and suppress COVID-19,
including molecular, antigen and serological tests.
(2) Manufacturing, procurement and distribution of
tests, testing equipment and testing supplies, including
personal protective equipment needed for administering tests.
(3) The development and validation of rapid, molecular
point-of-care tests and other tests.
(4) Support for workforce and epidemiology.
2020/90MSP/HB2455A05439 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46